Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumio Ohtsuki

Showing results (11-20 of 229) with videos related to

Pageof 23
Sort By:
Drug Discovery Today. Technologies|December 15, 2021
Advances in sample preparation for membrane proteome quantificationTakeshi Masuda, Shingo Ito, Sumio Ohtsuki
Molecular Pharmacology|July 5, 2007
Insulin facilitates the hepatic clearance of plasma amyloid beta-peptide (1 40) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytesChihiro Tamaki, Sumio Ohtsuki, Tetsuya Terasaki
International Journal of Pharmaceutics|November 14, 2002
Recent advances in the brain-to-blood efflux transport across the blood-brain barrierKen-ichi Hosoya, Sumio Ohtsuki, Tetsuya Terasaki
Fluids and Barriers of the CNS|December 20, 2024
Isolation method of brain microvessels from small frozen human brain tissue for blood-brain barrier protein expression analysisSeiryo Ogata, Shingo Ito, Takeshi Masuda, et al.
Pharmaceutical Research|September 21, 2022
Human Hepatic Transporter Signature Peptides for Quantitative Targeted Absolute Proteomics: Selection, Digestion Efficiency, and Peptide StabilityAyano Mori, Takeshi Masuda, Shingo Ito, et al.
Pharmaceutical Research|November 23, 2021
Effect of Insulin Receptor-Knockdown on the Expression Levels of Blood-Brain Barrier Functional Proteins in Human Brain Microvascular Endothelial CellsHinako Nagano, Shingo Ito, Takeshi Masuda, et al.
Journal of Pharmaceutical Sciences|May 12, 2011
Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospectsSumio Ohtsuki, Yasuo Uchida, Yoshiyuki Kubo, et al.
Drug Metabolism and Pharmacokinetics|April 29, 2023
Effect of antibiotic-administration period on hepatic bile acid profile and expression of pharmacokinetic-related proteins in mouse liver, kidney, and brain capillariesRyotaro Yagi, Takeshi Masuda, Shingo Ito, et al.
Pharmaceutical Research|August 2, 2019
Changes of Blood-Brain Barrier and Brain Parenchymal Protein Expression Levels of Mice under Different Insulin-Resistance Conditions Induced by High-Fat DietSeiryo Ogata, Shingo Ito, Takeshi Masuda, et al.
Pharmaceutical Research|November 12, 2024
Regulatory Role of eIF2αK4 in Amino Acid Transporter Expression in Mouse Brain Capillary Endothelial CellsYudai Hamada, Takeshi Masuda, Shingo Ito, et al.
Pageof 23

Showing results (11-20 of 229) with videos related to

Sort By:
Pageof 23
Drug Discovery Today. Technologies|December 15, 2021
Advances in sample preparation for membrane proteome quantificationTakeshi Masuda, Shingo Ito, Sumio Ohtsuki
Molecular Pharmacology|July 5, 2007
Insulin facilitates the hepatic clearance of plasma amyloid beta-peptide (1 40) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytesChihiro Tamaki, Sumio Ohtsuki, Tetsuya Terasaki
International Journal of Pharmaceutics|November 14, 2002
Recent advances in the brain-to-blood efflux transport across the blood-brain barrierKen-ichi Hosoya, Sumio Ohtsuki, Tetsuya Terasaki
Fluids and Barriers of the CNS|December 20, 2024
Isolation method of brain microvessels from small frozen human brain tissue for blood-brain barrier protein expression analysisSeiryo Ogata, Shingo Ito, Takeshi Masuda, et al.
Pharmaceutical Research|September 21, 2022
Human Hepatic Transporter Signature Peptides for Quantitative Targeted Absolute Proteomics: Selection, Digestion Efficiency, and Peptide StabilityAyano Mori, Takeshi Masuda, Shingo Ito, et al.
Pharmaceutical Research|November 23, 2021
Effect of Insulin Receptor-Knockdown on the Expression Levels of Blood-Brain Barrier Functional Proteins in Human Brain Microvascular Endothelial CellsHinako Nagano, Shingo Ito, Takeshi Masuda, et al.
Journal of Pharmaceutical Sciences|May 12, 2011
Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospectsSumio Ohtsuki, Yasuo Uchida, Yoshiyuki Kubo, et al.
Drug Metabolism and Pharmacokinetics|April 29, 2023
Effect of antibiotic-administration period on hepatic bile acid profile and expression of pharmacokinetic-related proteins in mouse liver, kidney, and brain capillariesRyotaro Yagi, Takeshi Masuda, Shingo Ito, et al.
Pharmaceutical Research|August 2, 2019
Changes of Blood-Brain Barrier and Brain Parenchymal Protein Expression Levels of Mice under Different Insulin-Resistance Conditions Induced by High-Fat DietSeiryo Ogata, Shingo Ito, Takeshi Masuda, et al.
Pharmaceutical Research|November 12, 2024
Regulatory Role of eIF2αK4 in Amino Acid Transporter Expression in Mouse Brain Capillary Endothelial CellsYudai Hamada, Takeshi Masuda, Shingo Ito, et al.
Pageof 23